Compare FLNT & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLNT | SRTS |
|---|---|---|
| Founded | 2001 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.5M | 79.3M |
| IPO Year | 2009 | 2016 |
| Metric | FLNT | SRTS |
|---|---|---|
| Price | $3.36 | $4.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $2.50 | ★ $6.67 |
| AVG Volume (30 Days) | 24.2K | ★ 91.9K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1266.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $254,623,000.00 | $41,807,000.00 |
| Revenue This Year | N/A | $31.80 |
| Revenue Next Year | $11.71 | $32.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 71.31 |
| 52 Week Low | $1.50 | $3.03 |
| 52 Week High | $4.00 | $5.92 |
| Indicator | FLNT | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 56.89 |
| Support Level | $2.88 | $4.14 |
| Resistance Level | $3.57 | $4.85 |
| Average True Range (ATR) | 0.21 | 0.26 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 57.04 | 75.14 |
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.